Estrogen Receptor Antagonists
- Name
- Estrogen Receptor Antagonists
- Accession Number
- DBCAT001199
- Description
Compounds and drugs that bind to and block or inhibit the activation of ESTROGEN RECEPTORS.
- Drugs
Drug Drug Description Fulvestrant An estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-. Elacestrant An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. - Drugs & Drug Targets